FILE PHOTO: A Palestinian health worker prepares AstraZeneca vaccine against the coronavirus disease (COVID-19) during a vaccination drive in Tubas, in the Israeli-occupied West Bank March 25, 2021. Picture taken March 25, 2021. REUTERS/Raneen Sawafta
MELBOURNE (Reuters) - Australia is investigating whether a blood clotting case recorded on Friday is related to the AstraZeneca coronavirus vaccine, a health official said, raising concern in a nation where most people are expected to receive the drugmaker's shot. A 44-year-old man was admitted to a Melbourne hospital with clotting days after receiving the AstraZeneca vaccine, suffering serious thrombosis and a low count of platelets, or blood cells that stop bleeding.
"Investigators have not at this time confirmed a causal link with the COVID-19 AstraZeneca vaccine, but investigations are ongoing," the deputy chief medical officer, Michael Kidd, told a televised briefing.
Limited time offer:
Just RM5 per month.
